Accessibility Menu
Doximity Stock Quote

Doximity (NYSE: DOCS)

$27.75
(-16.7%)
-5.57
Price as of February 6, 2026, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$27.75
Daily Change
(-16.7%) $5.57
Day's Range
$23.68 - $27.88
Previous Close
$27.75
Open
$23.68
Beta
N/A
Volume
1,523,428
Average Volume
3,280,588
Market Cap
$5.2B
Market Cap / Employee
$27.73M
52wk Range
$23.66 - $85.21
Revenue
N/A
Gross Margin
0.90%
Dividend Yield
N/A
EPS
$1.19
CAPs Rating
N/A
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Doximity Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
DOCS-52.4%N/AN/A-48%
S&P+13.95%+78.35%+12.25%+62%

Doximity Company Info

Doximity, Inc. operates an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

News & Analysis

The Fool has written over 100 articles on Doximity.

Financial Health

General

Q4 2025YOY Change
Revenue$185.05M9.8%
Gross Profit$166.35M7.7%
Gross Margin89.89%-1.7%
Market Cap$8.34B-16.4%
Market Cap / Employee$10.04M0.0%
Employees8300.4%
Net Income$61.56M-18.1%
EBITDA$77.85M-5.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$64.84M-60.8%
Accounts Receivable$158.09M13.3%
Inventory00.0%

Liabilities

Q4 2025YOY Change
Long Term Debt$8.61M-19.4%
Short Term Debt$2.08M-7.8%

Ratios

Q4 2025YOY Change
Return On Assets20.56%2.0%
Return On Invested Capital15.55%1.5%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$58.58M-7.6%
Operating Free Cash Flow$60.89M-6.6%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Earnings52.4052.6658.3537.18-30.23%
Price to Book10.5610.7013.377.60-26.72%
Price to Sales20.6520.9323.6313.83-29.52%
Price to Tangible Book Value11.5911.6814.668.57-25.37%
Price to Free Cash Flow TTM44.1642.9447.0528.71-38.29%
Enterprise Value to EBITDA210.47200.25193.64104.01-13.71%
Free Cash Flow Yield2.3%2.3%2.1%3.5%62.05%
Return on Equity22.5%24.3%24.6%23.8%12.12%
Total Debt$12.40M$11.84M$11.27M$10.69M-17.42%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.